Webhaber
Experts temper hope for new FDA-approved Alzheimer’s drug

Experts temper hope for new FDA-approved Alzheimer’s drug

Lecanemab, marketed under the brand name Leqembi, is the second Alzheimer’s drug to receive U.S. regulatory approval in two decades, but Canadian experts say its potential benefits come with significant caveats

The Globe And Mail The Globe And Mail | Go to detail of news source

The Globe And Mail , Benzer haberler

The Globe And Mail Parks Canada says whirling disease could ‘decimate’ fish, urges B.C. closure respect Parks Canada says whirling disease could ‘decimate’ fish, urges B.C. closure respect
The Globe And Mail Quebec appeal court overturns conditional discharge given to man guilty of sexual assault Quebec appeal court overturns conditional discharge given to man guilty of sexual assault
The Globe And Mail Alarm grows as Saskatchewan bars third-party sexual health, sexual abuse prevention educators from classrooms Alarm grows as Saskatchewan bars third-party sexual health, sexual abuse prevention educators from classrooms
The Globe And Mail Fish sounds could help scientists understand their ocean world Fish sounds could help scientists understand their ocean world
The Globe And Mail Overwhelmed food charities say solution to hunger is higher incomes, not more funding Overwhelmed food charities say solution to hunger is higher incomes, not more funding
The Globe And Mail ‘I wasn’t aware of it’: Doug Ford denies involvement in municipal land decisions ‘I wasn’t aware of it’: Doug Ford denies involvement in municipal land decisions